在症状性动脉狭窄症的干预时间
Jessica Ding1, Thomas S Maldonado1
1NYU Langone Health Division of Vascular and Endovascular Surgery, New York, NY.
Annals of vascular surgery
|September 30, 2024
概括
定时动脉狭窄干预平衡了外科手术期间的风险和复发性中风风险. 早期干预可能会增加术后中风,而延迟干预会增加中风复发风险.
科学领域:
- 血管外科 血管外科
- 神经学 神经学
- 干预心脏病学 干预心脏病学
背景情况:
- 症状性动脉狭窄症涉及神经学缺陷,与动脉狭窄症>50%相关.
- 手术干预有利于症状性动脉狭窄,但最佳时间尚不清楚.
- 干预时间必须平衡术后风险 (在48小时内更高) 和复发性中风风险 (在14天后更高).
研究的目的:
- 探索干预症状性动脉狭窄的最佳时间.
- 分析影响术后中风和死亡风险的因素.
- 为了比较不同手术干预的结果.
主要方法:
- 对以前关于症状性动脉狭窄干预的研究进行了审查.
- 分析影响外科手术期间风险的因素 (神经缺陷敏度,狭窄程度,并发症).
- 动脉内关节切除术和跨动脉再血管化结果的比较.
主要成果:
- 干预的最佳时机需要平衡急性外科手术后风险与复发性中风风险.
- 诸如神经缺陷敏度,狭窄程度和并发症等因素会影响外科手术期间的风险.
- 在最近的研究中,穿关节再血管化显示出与关节内关节切除术类似的结果.
结论:
- 动脉狭窄干预的最佳时间对于最大限度地降低整体中风风险至关重要.
- 在确定干预时间时,必须考虑个别患者的因素.
- Carotid Endarterectomy 和 Transcarotid Revascularization 都是症状性心血管狭窄的可行的选择.
更多相关视频
07:46Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
Published on: May 9, 2013
29.1K
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
4.8K
相关概念视频
01:28Acute Coronary Syndrome IV: Interprofessional Care
3
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
01:27Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
01:26Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
01:26Aneurysm III: Interprofessional Care
3
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
3
01:27Peripheral Artery Disease III: Interprofessional Care
3
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
3
01:26Angina IV: Management
3
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
3